Number of pages: 100 | Report Format: PDF | Published date: June 01, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 179.88 million |
Revenue Forecast in 2031 |
US$ 549.37 million |
CAGR |
12.10% |
Base Year for Estimation |
2022 |
Forecast Period |
2023 to 2031 |
Historical Year |
2021 |
Segments Covered |
Product Type, Patient Type, End User, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global bone conduction hearing devices market was valued at US$ 179.88 million in 2022 and is expected to register a revenue CAGR of 12.10% to reach US$ 549.37 million by 2031.
Bone Conduction Hearing Devices Market Fundamentals
Osseointegrated or bone-anchored devices, also known as bone conduction hearing devices or hearing systems, are cutting-edge medical devices approved by the Food and Drug Administration to treat specific forms of hearing loss. For bone conduction hearing systems, surgical and non-surgical alternatives are available. Hearing aids that use bone conduction enhance sound by sending vibrations through the skull's bones and directly stimulating the cochlea (see How the Ear Works). This kind of amplification does not require any portion of the device to be inserted into the ear canal and instead transmits sound through the middle ear, unlike a standard hearing aid.
The international standard of treatment for treating moderate to severe hearing loss is conventional air conduction hearing aids (ACHA), while cochlear implants are only used to treat profound to severe hearing loss. Implantable hearing devices are an innovative solution that meets the needs of patients with moderate to severe hearing loss who do not benefit from ACHAs or cannot use them for various reasons. Additionally, people with conductive hearing loss, in which sound is prevented from reaching the inner ear entirely or only partially, can benefit from bone conduction devices. This kind of hearing loss may be brought on by problems with the middle or outer ear, including ear infections, congenital anomalies, or trauma. Using bone conduction devices can also be advantageous for people with mixed hearing loss, which combines conductive and sensorineural hearing loss. By bypassing the conductive component and stimulating the inner ear directly, the devices correct the hearing loss caused by conductive pathways.
Bone Conduction Hearing Devices Market Dynamics
One of the key reasons fueling the market's expansion is the rising prevalence of hearing loss worldwide. For instance, according to the National Institute on Deafness and Other Communication Disorders (NIDCD), within the population over 60, there is a high incidence rate. Partial hearing loss also affects the pediatric population. Nearly 4 out of every 1,000 children in the United States are born with partial or total detectable levels of hearing loss. Additionally, according to regular hearing tests, one in ten Americans aged 11 or older has total or partial hearing loss. Adult bone conduction hearing aids are in greater demand since hearing loss among the elderly population is rising.
Additionally, the expansion of the pediatric/child bone conduction hearing devices market is predicted to be boosted by recent technical developments in diagnostic tools for hearing loss in children and newborns. For instance, in December 2019, the new Cochlear Osia 2 System was approved by the U.S. Food and Drug Administration (FDA), according to Cochlear Limited (ASX: COH), the world leader in implanted hearing solutions. The Osia System is the first active osseointegrated steady-state implant (OSI) in the world, a novel class of bone conduction hearing aids that sends sound vibrations directly to the inner ear by avoiding damaged parts of the natural hearing system.
Bone Conduction Hearing Devices Market Ecosystem
The global bone conduction hearing devices market is analyzed from the following perspectives by product type, patient type, end user, and region.
Bone Conduction Hearing Devices Market by Product Type
Based on product type, the global bone conduction hearing devices market is segmented into bone anchored hearing aids and traditional bone conduction hearing aids.
The bone anchored hearing aids segment will likely dominate the market during the forecast period. The bone-anchored Hearing Aid (BAHA) is a surgically implanted gadget that transmits sound vibrations directly to the inner ear through the skull bone, assisting those who have hearing loss and avoiding specific issues. When at least one inner ear is functioning regularly, these operate optimally. Adult bone-anchored hearing aids are in great demand due to the rising prevalence of hearing loss among the elderly population. Furthermore, the child/pediatric bone conduction hearing aids market is anticipated to rise as a result of rising awareness and technological developments in the detection of hearing loss in babies and children. The adoption of new technologies is being fueled by the expansion of healthcare infrastructure globally and increased healthcare spending which is also driving the industry.
Bone Conduction Hearing Devices Market by Patient Type
Based on patient type, the global bone conduction hearing devices market is segmented into children/pediatrics and adults.
The adult segment will likely dominate the market during the forecast period due to the rising global elderly population, which will considerably increase throughout the predicted period. According to World Health Organization 2022, 80% of the world's elderly population will reside in low- and middle-income nations by 2050. More quickly than in the past, the population is aging. People 60 years of age and older will outnumber youngsters under the age of five in 2020. The percentage of the global population over 60 years old will nearly treble from 12% to 22% between 2015 and 2050. During the projected period, this aspect is predicted to increase demand for bone-conduction hearing devices among the adult population, spurring market expansion. The adult market accounted for a sizeable portion of revenue in 2022 and is anticipated to see strong penetration rates, partly due to growing disposable money and increased awareness of improved living circumstances among adults worldwide, particularly in developed nations like the U.S.
Bone Conduction Hearing Devices Market by End User
Based on end user, the global bone conduction hearing devices market is segmented into hospitals, ENT clinics, ambulatory surgical centers, and others.
The hospital segment is likely to dominate the market during the forecast period. The technology of hearing aids using bone conduction has advanced significantly over time. These gadgets have advanced in sophistication, providing the wearer with increased comfort and higher sound quality. More hospitals may start using these devices as a practical treatment option for people with particular forms of hearing loss as technology develops. In addition, those with conductive hearing loss or single-sided deafness were the main users of bone-conduction hearing devices at first. However, the use of bone conduction devices has grown as our knowledge of hearing loss and available treatments has advanced. They are also employed in patients with both hearing loss and specific ear-related medical disorders, which has increased their use in hospitals.
Bone Conduction Hearing Devices Market by Region
Based on region, the global bone conduction hearing devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Throughout the projection period, the North American region is predicted to have a large market share. The market's expansion may be ascribed to significant players in the bone conduction hearing devices industry and raising public awareness of health and physical difficulties.
Europe is anticipated to be the second-most productive market. The market in this region is being driven by factors like the adoption of novel medical devices, an increase in the prevalence of hearing loss, and growing R&D activities to create technologically advanced products in this region, which is likely to encourage the growth of bone conduction hearing aids.
Asia-Pacific, however, is anticipated to have rapid expansion in the near future and registered the fastest revenue CAGR of 13.4%. The rise in the older population, the expansion of manufacturers into developing Asian countries, and the prevalence of whole or partial hearing loss all contribute to the market's expansion. According to World Health Organization 2023, At least 700 million individuals will need hearing rehabilitation by 2050, it is predicted that approximately 2.5 billion people will have some degree of hearing loss. Due to dangerous listening habits, almost 1 billion young individuals risk developing permanent, preventable hearing loss. To expand ear and hearing care services internationally, an incremental yearly investment of less than US$ 1.40 per person is required. The market in Latin America and the Middle East & Africa is anticipated to grow moderately throughout the forecast period.
Bone Conduction Hearing Devices Competitive Landscape
Some of the prominent market players in the global bone conduction hearing devices market include,
Bone Conduction Hearing Devices Strategic Development
Osseointegrated or bone-anchored devices, also known as bone conduction hearing devices or hearing systems, are cutting-edge medical gadgets approved by the Food and Drug Administration to treat specific forms of hearing loss.
The bone anchored hearing aids segment led the global bone conduction hearing devices market.
North America is dominating the global bone conduction hearing devices market.
The estimated market size of the bone conduction hearing devices market in 2031 will be US$ 549.37 million.
The revenue CAGR of the bone conduction hearing devices market during the forecast period will be 12.10%.
*Insights on financial performance are subject to the availability of information in the public domain